Data on mRNA vaccines sent by Moderna to European regulators before the COVID-19 outbreak included early tests of the mRNA ...

A small, early trial of a vaccine that mobilizes the immune system to battle advanced kidney cancers appears successful, ...

(Reuters) -U.S. drugmaker Pfizer beat Wall Street estimates for fourth-quarter profit on Tuesday, helped by strong sales of ...

A Massachusetts biopharma giant is at the center of preparations already underway if bird flu mutates and begins to find ...

2 spike compared with either XBB.1.5 or the ancestral WA1 spike. This finding highlights the relevance of closely monitoring the immune evasiveness of emerging variants to expedite the development and ...

With the rise of omicron came the fall of long-lasting protection from reinfection with the pandemic coronavirus SARS-CoV-2, ...

Lesley Jenkins had surgery to remove a tumour that was discovered following a routine bowel test.

With a substantial number of mutations in its Spike protein, the SARS-CoV-2 Omicron variant is prone to immune evasion and led to the reduced efficacy of approved vaccines. Thus, emerging variants ...

SARS-CoV-2 spike RBD IgG ELISA was carried out as previously described13 14 (online supplemental methods). The primary analysis was to compare the relationship between microbiome profile and immune ...

A nasal vaccine for COVID-19 – based on technology developed at Washington University in St. Louis – is poised to enter a phase 1 clinical trial in the U.S. after an investigational new drug ...